Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.

MLA

Frei, Anja L., et al. “Multiplex Analysis of Intratumoural Immune Infiltrate and Prognosis in Patients with Stage II-III Colorectal Cancer from the SCOT and QUASAR 2 Trials: A Retrospective Analysis.” The Lancet. Oncology, vol. 25, no. 2, Feb. 2024, pp. 198–211. EBSCOhost, https://doi.org/10.1016/S1470-2045(23)00560-0.

APA

Frei, A. L., McGuigan, A., Sinha, R. R. A. K., Jabbar, F., Gneo, L., Tomasevic, T., Harkin, A., Iveson, T., Saunders, M. P., Oien, K. A., Maka, N., Pezzella, F., Campo, L., Browne, M., Glaire, M., Kildal, W., Danielsen, H. E., Hay, J., Edwards, J., … Koelzer, V. H. (2024). Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. The Lancet. Oncology, 25(2), 198–211. https://doi.org/10.1016/S1470-2045(23)00560-0

Chicago

Frei, Anja L, Anthony McGuigan, Ritik R A K Sinha, Faiz Jabbar, Luciana Gneo, Tijana Tomasevic, Andrea Harkin, et al. 2024. “Multiplex Analysis of Intratumoural Immune Infiltrate and Prognosis in Patients with Stage II-III Colorectal Cancer from the SCOT and QUASAR 2 Trials: A Retrospective Analysis.” The Lancet. Oncology 25 (2): 198–211. doi:10.1016/S1470-2045(23)00560-0.